Latest News
Definium Therapeutics, Inc. (DFTX) Q2 2026 Earnings Call Prepared Remarks Transcript
Definium Therapeutics, Inc. (DFTX) Q2 2026 Earnings Call Prepared Remarks Transcript
Iochpe-Maxion S.A. (IOCJY) Q2 2026 Earnings Call Transcript
Iochpe-Maxion S.A. (IOCJY) Q2 2026 Earnings Call Transcript
Diamond Hill Small-Mid Cap Fund Q2 2026 Portfolio Review
The Fund increased 9.71% compared to a 20.26% increase for the Russell 2500 Index. We initiated a position in managed care provider Centene. Shares of website design software provider Wix.com were sol
ROSEN, A LONGSTANDING FIRM, Encourages Genius Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action Against Citadel Securities LLC and Virtu Americas LLC - GNS
New York, New York--(Newsfile Corp. - August 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS)
ROSEN, A TOP-RANKED LAW FIRM, Encourages America's Car-Mart, Inc. Investors to Inquire About Securities Class Action Investigation - CRMT
New York, New York--(Newsfile Corp. - August 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Americ
Oil rises amid supply disruption fears following Iran's restrictive draft plan for the Strait of Hormuz
Worries over oil supply disruptions continue to linger after Iran published a restrictive draft plan for the Strait of Hormuz. According to the apparent draft plan published by Iran, the country would
Dorel Industries Inc. (DII.B:CA) Q2 2026 Earnings Call Transcript
Dorel Industries Inc. (DII.B:CA) Q2 2026 Earnings Call Transcript
ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
New York, New York--(Newsfile Corp. - August 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Elauwi
ROSEN, REGARDED INVESTOR COUNSEL, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
New York, New York--(Newsfile Corp. - August 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyM
Cable One, Inc. (CABO) Q2 2026 Earnings Call Transcript
Cable One, Inc. (CABO) Q2 2026 Earnings Call Transcript
The Trade Desk, Inc. (TTD) Q2 2026 Earnings Call Transcript
The Trade Desk, Inc. (TTD) Q2 2026 Earnings Call Transcript
CNB Financial Corporation (CCNE) Q2 2026 Earnings Call Transcript
CNB Financial Corporation (CCNE) Q2 2026 Earnings Call Transcript
Premium Brands Holdings Corporation (PBH:CA) Q2 2026 Earnings Call Transcript
Premium Brands Holdings Corporation (PBH:CA) Q2 2026 Earnings Call Transcript
Fox Factory Holding Corp. (FOXF) Q2 2026 Earnings Call Transcript
Fox Factory Holding Corp. (FOXF) Q2 2026 Earnings Call Transcript
Meta ordered to pay $567 million into abatement fund as remedy to child harms case in New Mexico
A judge in New Mexico ordered Meta to pay $567 million into an abatement fund after a jury ruled the company willfully violated the state's unfair practices act. Meta's platforms are contributing to t
Orion Digital Corp. (ORIO:CA) Q2 2026 Earnings Call Transcript
Orion Digital Corp. (ORIO:CA) Q2 2026 Earnings Call Transcript
BRC Group Holdings, Inc. (RILY) Q2 2026 Earnings Call Transcript
BRC Group Holdings, Inc. (RILY) Q2 2026 Earnings Call Transcript
Aspen Aerogels, Inc. (ASPN) Q2 2026 Earnings Call Transcript
Aspen Aerogels, Inc. (ASPN) Q2 2026 Earnings Call Transcript
Burford Capital Limited (BUR) Q2 2026 Earnings Call Transcript
Burford Capital Limited (BUR) Q2 2026 Earnings Call Transcript
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit
NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of ARS Pharmaceuticals, Inc. (NASD